US20110257410A1 - Methods for the preparation of fungicides - Google Patents

Methods for the preparation of fungicides Download PDF

Info

Publication number
US20110257410A1
US20110257410A1 US13/142,084 US200913142084A US2011257410A1 US 20110257410 A1 US20110257410 A1 US 20110257410A1 US 200913142084 A US200913142084 A US 200913142084A US 2011257410 A1 US2011257410 A1 US 2011257410A1
Authority
US
United States
Prior art keywords
compound
formula
independently
ligand
mol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/142,084
Other languages
English (en)
Inventor
George Robert Hodges
Lisa Mitchell
Alan James Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Crop Protection LLC
Original Assignee
Syngenta Crop Protection LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Crop Protection LLC filed Critical Syngenta Crop Protection LLC
Priority to US13/142,084 priority Critical patent/US20110257410A1/en
Publication of US20110257410A1 publication Critical patent/US20110257410A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C25/00Compounds containing at least one halogen atom bound to a six-membered aromatic ring
    • C07C25/18Polycyclic aromatic halogenated hydrocarbons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72Hydrazones
    • C07C251/82Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/18Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C43/192Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/687Unsaturated compounds containing a keto groups being part of a ring containing halogen
    • C07C49/693Unsaturated compounds containing a keto groups being part of a ring containing halogen polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Definitions

  • the present invention relates to methods for the preparation of pyrazolyl-4-carboxylic acid benzonorbornen-5-yl-amides and also to intermediates for use in such methods.
  • Pyrazolyl-4-carboxylic acid benzonorbornen-5-yl-amides for example 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-isopropyl-1,2,3,4-tetrahydro-1,4-methano-naphthalen-5-yl)-amide, are valuable fungicides. These are described in WO 04/035589.
  • WO 04/035589 describes processes for the preparation of pyrazolyl-4-carboxylic acid benzonorbornen-5-yl-amides, as shown in schemes 1 and 2 below. Het, R′, R 1 R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , X and Y are as described in WO 04/035589.
  • a compound of formula (Ia) may be prepared by reacting an ester of formula (IIa) with an aniline of formula (IIIa) in the presence of NaN(TMS) 2 .
  • a compound of formula (Ia) may be prepared by reacting an acid of formula (II′a) with an aniline of formula (IIIa) in the presence of an activating agent, such as BOP—Cl, and two equivalents of a base, such as triethylamine.
  • a halo-acid chloride of formula (II′′a) is obtained from an acid of formula (II′a) by treatment with a halogenating agent such as thionyl chloride, which is then reacted with an aniline of formula (IIIa) in the presence of a base to give a compound of formula (Ia).
  • a halogenating agent such as thionyl chloride
  • WO 2007/031323 describes improvements in the process for the preparation of the pyrazolyl-4-carboxylic acid benzonorbornen-5-yl-amides but the improvements relate to earlier steps of the synthetic pathway described in WO 04/035589.
  • pyrazolyl-4-carboxylic acid benzonorbornen-5-yl-amides may be prepared in high yield by reacting an ortho-substituted benzonorbornene compound with a pyrazolyl-4-amide in the presence of a catalyst comprising a metal and a ligand.
  • this invention relates to the synthesis of pyrazolyl-4-carboxylic acid benzonorbornen-5-yl-amides by reacting an ortho-substituted benzonorbornene compound with a pyrazolyl-4-amide in the presence of a catalyst comprising a metal.
  • Y is CHCHR 6 (R 7 ), C ⁇ C(A)Z, CY 2 (R 2 )Y 3 (R 3 ), or C ⁇ N—NR 4 (R 5 );
  • Y 2 and Y 3 are, independently, O, S, N; A and Z are, independently, C 1-6 alkyl;
  • R 1 is CF 3 or CF 2 H
  • R 2 and R 3 are, independently, C 1-8 alkyl, wherein R 2 and R 3 are optionally joined to form a 5-8 membered ring;
  • R 4 and R 5 are, independently, C 1-8 alkyl;
  • B is a single bond or a double bond;
  • R 6 and R 7 are, independently, hydrogen or C 1-6 alkyl; comprising the step of reacting a compound of formula (II):
  • R 1 is as defined for the compound of formula (I); in the presence of a catalyst, which catalyst comprises copper and a ligand.
  • the invention includes methods of preparing isomers of compounds of formula (I), including stereoisomers, geometric isomers and any tautomers.
  • the invention includes methods of preparing the stereoisomers of compounds of the formula (I), e.g. compounds in which the Y moiety is above or below the plane of the aromatic ring.
  • the invention also includes methods of preparing salts of the compound of formula (I).
  • any reference to a particular compound includes references to any stereoisomers, geometric isomers, tautomers, and salts of the compound unless otherwise stated.
  • a and Z are each, independently, C 1-4 alkyl.
  • a and Z are each, independently, CH 3 .
  • Y 2 and Y 3 are each, independently, O or S.
  • Y 2 and Y 3 are each, independently, O.
  • B is a single bond.
  • R 1 is CF 3 , CHF 2 or CH 2 F.
  • R 1 is CF 3 or CHF 2 .
  • R 1 is CHF 2 .
  • R 2 and R 3 are each, independently, C 1-4 alkyl; or R 2 and R 3 are together a 4-6 membered ring.
  • R 2 and R 3 are each, independently, methyl or ethyl; or R 2 and R 3 are together an ethylene or propylene group.
  • R 2 and R 3 are each, independently, methyl or R 2 and R 3 are together an ethylene group.
  • R 4 and R 5 are each, independently, C 1-4 alkyl.
  • R 4 and R 5 are each, independently, methyl or ethyl, preferably methyl.
  • R 6 and R 7 are each, independently, methyl or ethyl, preferably methyl.
  • Y is CHCHR 6 (R 7 ) or C ⁇ C(A)Z.
  • Y is CHCH(CH 3 )CH 3 or C ⁇ C(CH 3 )CH 3 .
  • Y is CHCH(CH 3 )CH 3 .
  • X e.g. in formula (II)
  • X is Cl, Br, or I, more preferably Cl, e.g. the compound of formula (II) may be a benzonorbornen-5-yl-chloride.
  • R* is an electron pair, hydrogen, alkyl, cycloalkyl, or aryl.
  • X may be triflate, tosylate, mesylate, or nonaflate, e.g. it may be trifluoromethanesulfonate ester, p-toluenesulfonate ester, methanesulfonate, or nonafluorobutanesulfonate ester.
  • X may be tosylate or mesylate.
  • Carbon chains e.g. alkyl, may be branched or unbranched.
  • Y is CHCHR 6 (R 7 ) or C ⁇ C(A)Z;
  • B is a single bond or a double bond
  • a and Z are, independently, C 1-6 alkyl
  • R 1 is CF 3 or CF 2 H
  • R 6 and R 7 are, independently, hydrogen or C 1-6 alkyl; comprising the step of reacting a compound of formula (IIA):
  • R 1 is as defined for the compound of formula (IA); in the presence of a catalyst, which catalyst comprises copper and a ligand.
  • the copper may be a copper atom or ion and, for example, may be derived from any copper salt, such as Cu(I) or Cu(II).
  • the catalyst of the invention comprises CuCl, CuBr, CuI or a mixture of two or more thereof.
  • the ligand comprised by the catalyst may be a chelating ligand, e.g. a bidendate ligand.
  • the one or more atoms on the ligand mediating chelation usually Lewis basic atoms, may be independently selected from nitrogen, oxygen, phosphorus or arsenic, and preferably are nitrogen.
  • the catalyst may comprise more than one type of ligand.
  • the catalyst may comprise one or more other types of ligand in addition to the ligand referred to.
  • Suitable ligands include alkyl alcohol, aryl alcohol e.g. phenol, alkyl amine, diamine e.g. 1,2-diamine or 1,3-diamine, 1,2-aminoalcohol, 1,2-aminoether e.g. tris(3,6,-dioxaheptyl)amine, 1,2-aminoacid e.g. pipecolinic acid, 1,2-diol, imidazolium carbene, pyridine, 1,10-phenanthroline, 1,3-diketone e.g. 2,4-pentadione; each optionally substituted.
  • the ligand is a diamine, e.g. an optionally substituted 1,2-diamine and/or an optionally substituted 1,10-phenanthroline.
  • the ligand or ligands may be 1,2-diaminoalkane, 1,3-diaminoalkane, 1,2-diaminocyclohexane, 1,10-phenanthroline, 2-hydroxyethyl amine, or 1,2-diaminoethane, each optionally substituted.
  • the ligand is optionally substituted 1,2-diaminocyclohexane or optionally substituted 1,2 ethylenediamine such as 1,2-diaminocyclohexane, N,N′-dimethyl-1,2-diaminocyclohexane, N-tolyl-1,2-diaminocyclohexane, 1,2 ethylenediamine, N,N′-dimethyl ethylenediamine.
  • the ligand is N,N′ dimethyl 1,2 diamine cyclohexane, N,N′ dimethyl 1,2 diethylamine, or N1-methyl-propane-1,3-diamine.
  • the ligand is N,N′ dimethyl 1,2 diamine cyclohexane or N,N′ dimethyl 1,2 diethylamine.
  • Suitable ligands include 2-phenylphenol, 2,6-dimethylphenol, 2-isopropylphenol, 1-naphthol, EDTA, 8-hydroxyquinoline, 8-aminoquinoline, DBU, 2-(dimethylamino)ethanol, ethylene glycol, N,N-diethylsalicylamide, 2-(dimethylamino)glycine, N,N,N′,N′-tetramethyl-1,2-diaminoethane, 4,7-diphenyl-1,10-phenanthroline, 4,7-dimethyl-1,10-phenanthroline, 5-methyl-1,10-phenanthroline, 5-chloro-1,10-phenanthroline, 5-nitro-1,10-phenanthroline, 4-(dimethylamino)pyridine, 2-(aminomethyl)pyridine, (methylimino)diacetic acid, ethanolamine, 1,2-diaminoethane, N,N′-dimethyl-1,2-d
  • the ligand is trans-N,N′-dimethyl-1,2-diaminocyclohexane.
  • the molar ratio of trans-N,N′-dimethyl-1,2-diaminocyclohexane to cis-N,N′-dimethyl-1,2-diaminocyclohexane in the reaction mixture is at least 55% to 45%, at least 60% to 40%, at least 70% to 30%, at least 80% to 20%, at least 90% to 10%, at least 95% to 5%, at least 99% to 1%.
  • the ligand may be substantially all trans-N,N′-dimethyl-1,2-diaminocyclohexane, e.g. 100% trans-N,N′-dimethyl-1,2-diaminocyclohexane.
  • optionally substituted means substituted or not substituted with one or more groups.
  • optionally substituted 1,2-diamine means 1,2-diamine or substituted 1,2-diamine.
  • Substituted 1,2-diamine includes 1,2-diamines substituted with one or more (functional) groups.
  • the ligand may be one particular isomer, e.g. a cis or trans isomer, or a mixture of isomers may be employed.
  • the ligand comprised by the catalyst is 1,2-diaminocyclohexane
  • the ligand may be cis-1,2-diaminocyclohexane, trans-1,2-diaminocyclohexane, or a mixture of cis- and trans-1,2 diaminocyclohexane.
  • the method may comprise initiating the reaction by providing the compound of formula III in liquid form prior to contacting the compound of formula III with the catalyst.
  • the method may comprise initiating the reaction by contacting the copper with the ligand in the presence of the compound of formula III, the compound of formula III being present in liquid form when the copper is contacted with the ligand.
  • the compound of formula III is in liquid form, for example, when dissolved in solvent or when melted.
  • Experimental results suggest that heating the catalyst in the absence of the compound of formula III can reduce the effectiveness of the catalyst.
  • the catalyst is not heated in the absence of the compound of formula III.
  • the invention may comprise bringing the copper into contact with the ligand in the presence of the compound of formula III, e.g. to form the catalyst, wherein the compound of formula III is provided such that it is capable of forming a complex with the copper and/or catalyst, e.g. when the copper is brought into contact with the ligand to form the catalyst.
  • the copper and ligand Prior to performing the step of bringing the copper into contact with the ligand the copper and ligand will be separate, i.e. not in contact.
  • the period during which the reaction is initiated includes the period prior to the formation of the compound of formula I during which the reagents and catalyst are combined.
  • the invention may comprise the steps:
  • Step a) may comprise contacting, e.g. dissolving, the compound of formula III in solvent. This may or may not result in all the compound of formula III used being dissolved in the solvent. Providing at least some compound of formula III is dissolved in solvent the compound of formula III will then be available for complexing with the catalyst.
  • At least 0.5, 0.7, 1.0, 1.5, 2, 3, 4, or even 5 molar equivalents of compound of formula III are dissolved, relative to the amount of copper, prior to contact of the compound of formula III with the catalyst. More preferably at least one molar equivalent of compound of formula III is dissolved relative to the amount of copper.
  • Step a) may comprise heating the compound of formula III.
  • the compound of formula III is heated to at least 40, 50, 60, 70, 80, 90, 100, 105, or even at least 110° C. in step a) e.g. prior to contacting the compound of formula III with both the copper and the ligand.
  • the reaction may be performed in a solvent, preferably an organic polar solvent.
  • a solvent preferably an organic polar solvent.
  • the compound of formula II and/or the ligand may serve as the solvent, or the solvent may be a different component.
  • the compound of formula III may serve as the solvent.
  • the method may comprise contacting the compound of formula III with solvent, e.g. the compound of formula II, and heating prior to contacting both of the ligand and the copper with the solvent. Heating may facilitate solvation of the compound of formula III, thereby allowing more compound of formula III to be available for complexing with the catalyst.
  • the solvent and compound of formula III is heated to at least 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, or even at least 140° C., e.g. 50-200° C., 80 to 180° C. 100-170° C., 130-160° C.° C. in step a) e.g. prior to contacting both of the copper and ligand in the solvent.
  • the solvent and compound of formula III may be heated at any of the foregoing temperatures for any desired length of time, e.g. 1 second to 24 hours, e.g. 1-1000 minutes, e.g. 10 to 500 minutes, e.g. 30 to 300 minutes.
  • the solvent and compound of formula III may be heated at any of the foregoing temperatures for at least 1, 10, 30, 60, or even at least 200 minutes.
  • the solvent with compound of formula III dissolved therein is heated at least at 100° C. for at least 100 minutes before the copper and ligand are both contacted with the solvent.
  • the method may include the additional step of melting the compound of formula II prior to contacting with the compound of formula III.
  • the compound of formula II may be combined with the other reagents at any stage.
  • the molar ratio of ligand to copper in the catalyst may be at least 10 to 1, at least 5 to 1, at least 3 to 1, at least 2.5 to 1, at least 2 to 1, at least 1.5 to 1, at least 1 to 1, at least 0.5 to 1, at least 0.1 to 1.
  • the molar ratio of ligand to copper in the catalyst may be less than 10 to 1, less than 5 to 1, less than 3 to 1, less than 2.5 to 1, less than 2 to 1, less than 1.5 to 1, or less than 1 to 1.
  • the molar ratio of ligand to copper in the catalyst may be in the range from 10:0.1 to 0.1:10, 5:1 to 1:5, 3:1 to 1:3, 2.5:1 to 1:2.5, 2:1 to 1:2, or 1.5:1 to 1:1.5.
  • the molar ratio of ligand to copper in the catalyst is preferably at least 1 to 1, e.g. at least 2 to 1, e.g. about 2.2 to 1.
  • Additional ligand may be added to the reaction mixture after the reaction has commenced, e.g. at one or more time points after commencement. Additional ligand may be added batch-wise, continuously or by a combination of both methods. Additional ligand may be added, for example, after at least 10, at least 20, at least 30, at least 40, at least 50, or at least 60 minutes, e.g. after at least 1, at least 2, at least 3, at least 4, or at least 5, hours after commencement.
  • the molar amount of additional ligand added during the course of the reaction may be at least 0.1, at least 0.5, at least 1, at least 2, at least 3, at least 4, at least 5, at least 8, or even at least 10 times the molar amount of copper present at reaction commencement.
  • the ligand may be present at about the same molar concentration as the copper, with additional ligand added during the reaction so that the final molar concentration of the ligand is at least 2, at least 2.5, at least 3, at least 3.5, at least 4, at least 4.5, at least 5, at least 8, or even at least 10 times the molar concentration of the copper.
  • additional copper may be added to the reaction mixture after the reaction has commenced, e.g. at one or more time points after commencement.
  • Additional copper may be added batch-wise, continuously or by a combination of both methods. Additional copper may be added, for example, after at least 10, at least 20, at least 30, at least 40, at least 50, or at least 60 minutes, e.g. after at least 1, at least 2, at least 3, at least 4, or at least 5, hours after commencement.
  • the molar amount of additional copper added during the course of the reaction may be at least 0.1, at least 0.5, at least 1, at least 2, at least 3, at least 4, at least 5, at least 8, or even at least 10 times the amount of copper present at commencement of the reaction.
  • the final molar concentration of the copper may be at least 2, at least 2.5, at least 3, at least 3.5, at least 4, at least 4.5, at least 5, at least 8, or even at least 10 times the molar concentration of the copper at reaction commencement.
  • additional copper and ligand may be added to the reaction mixture after the reaction has commenced, e.g. simultaneously, sequentially or separately.
  • the compound of formula (II) may be slowly added to the reaction.
  • the solvent and/or water may be distilled off during the reaction.
  • the solvent may then be recharged, e.g. to maintain reaction mobility.
  • the reaction of the invention may be performed in a solvent, particularly solvents in which the reactants and catalyst are substantially soluble.
  • solvents include ethers, such as diethylether, 1,2-dimethoxyethane, diethoxymethane, diglyme, t-butyl methyl ether, THF, 2-methyl-THF, dioxane; halogenated solvents such as chloroform, dichloromethane, dichloroethane, monochlorobenzene, dichlorobenzene, trichlorobenzene, 4-fluorotoluene; aliphatic (linear branched or cyclic) or aromatic hydrocarbon solvents such as benzene, xylene, toluene, benzene, ligroin, octane, heptane, hexane, pentane, methylcyclohexane, cyclohexane; esters and ketones such as ethyl
  • the solvent is an organic polar solvent, i.e. the solvent contains at least one carbon atom.
  • the solvent may be protic or aprotic.
  • solvents include ethers, such as diethylether, 1,2-dimethoxyethane, diethoxymethane, diglyme, t-butyl methyl ether, THF, 2-methyl-THF, dioxane; halogenated solvents such as chloroform, dichloromethane, dichloroethane, monochlorobenzene, dichlorobenzene, trichlorobenzene, 4-fluorotoluene; esters and ketones such as ethyl acetate, acetone 2-butanone, methylisobutylketone; amines such as anisole, polar aprotic solvents such as acetonitrile, dimethylsulfoxide, dimethylformamide, N-methylpyrrolidone, dimethylacetamide; and alcohols, such as
  • the solvent may be one in which halide salts have low solubility, e.g. the non-polar solvents mentioned above in which salts are substantially insoluble so that the halide ions released during the reaction are substantially removed from the reaction solution.
  • a combination of solvents may be used to tune the bulk solvent polarity verses halide salt solvation whereby one or more polar solvents, particularly polar aprotic solvents, and one or more non-polar solvent from the list above are combined.
  • An example is a mixture of DMF with xylene, which may in some cases contain about 50% v/v of each solvent.
  • the solvent may, for example, be DMF, diglyme, xylene, or mixtures thereof, e.g. diglyme and xylene.
  • the reaction of the invention may be performed using a solvent that has a boiling point (as determined under standard conditions) above 100° C., above 110° C., above 120° C., above 130° C., above 140° C., above 150° C., above 160°, or even above 170° C., particularly when the copper is copper.
  • the reaction of the invention is performed using a solvent that has a boiling point above 150° C.
  • the reaction may be carried out at a temperature of 0 to 200° C., in particular at least 100° C., at least 110° C., at least 120° C., at least 130° C., at least 140° C., at least 150° C., at least 160° C., at least 170° C., at least 180° C., or even at least 190° C.
  • the reaction may be performed in the range of from 0° C.-200° C., 100° C.-200° C., 110-200° C., 120° C.-200° C., 130° C.-200° C., 140° C.-200° C., 150° C.-200° C., 160° C.-200° C., 170° C.
  • the reaction of the invention may be performed at a higher pressure than atmospheric pressure.
  • the reaction may be performed at a pressure of about 1 bar or at least 1.1 bar, at least 1.2 bar, at least 1.3 bar, at least 1.4 bar, at least 1.5 bar, at least 1.6 bar, at least 1.7 bar, at least 1.8 bar, at least 1.9 bar, at least 2 bar, at least 3 bar, at least 4 bar, or even at least 5 bar, e.g. less than 10 bar, less than 5 bar, less than 2 bar, e.g.
  • 1 bar to 10 bar in the range of from 1 bar to 10 bar, 1 bar to 5 bar, 1 bar to 4 bar, 1 bar to 3 bar, 1 bar to 2 bar, 1 bar 1.9 bar, 1 bar to 1.8 bar, 1 bar to 1.7 bar, 1 bar to 1.6 bar, 1 bar to 1.5 bar, 1 bar to 1.4 bar, 1 bar to 1.3 bar, 1 bar to 1.2 bar, or even from 1 bar to 1.1 bar.
  • a higher pressure than 1 bar may be used when the solvent chosen has a boiling point less than the desired reaction temperature.
  • 1 bar may be generally considered to represent atmospheric pressure.
  • the reaction is performed in the presence of a base.
  • the base may be any Bronsted base, e.g. a carbonate, carboxylate, phosphate, oxide, hydroxide, alkoxide, aryloxide, amine, copper amide, fluoride, or guanidine, or a mixture of one or more thereof.
  • the base may be a metal salt of a carboxylic acid, e.g. sodium acetate, potassium phosphate, potassium carbonate, caesium carbonate, sodium tert-butoxide, sodium hydroxide, or mixtures thereof.
  • Suitable bases include K 3 PO 4 , K 2 CO 3 , Na 2 CO 3 , Ti 2 CO 3 , Cs 2 CO 3 , K(OtBu), Li(OtBu), Na(OtBu), K(OPh), Na(OPh), or mixtures thereof.
  • the base is a carbonate, e.g. potassium carbonate.
  • a suitable method is azeotropic removal of water.
  • Suitable apparatus for conducting azeotropic removal of water will be known to those skilled in the art.
  • the amount of copper employed may be less than 50 mol % based on the amount of compound (II), e.g. less than 25 mol %, less than 20 mol %, less than 10 mol %, less than 5 mol %, less than 2 mol %, less than 1 mol %, less than 0.5 mol %, or less than 0.1 mol % based on the amount of compound (II).
  • the amount of copper employed may be at least 0.01 mol % based on the amount of compound (II), e.g. at least 0.1 mol %, at least 1, at least 2, at least 5, or at least 10 mol % based on the amount of compound (II).
  • the amount of copper employed may be in the range from 0.01 to 50 mol % based on the amount of compound (II), in the range from 0. 1 to 25 mol %, 1 to 20 mol %, or in the range from 5 to 15 mol % based on the amount of compound (II).
  • the amount of copper is about 1 mol % based on the amount of compound (II), but may be up to 10 mol %.
  • the amount of copper employed may be less than 50 mol % based on the amount of compound (III), e.g. less than 25 mol %, less than 20 mol %, less than 10 mol %, less than 5 mol %, less than 2 mol %, less than 1 mol %, less than 0.5 mol %, or less than 0.1 mol % based on the amount of compound (III).
  • the amount of copper employed may be at least 0.01 mol % based on the amount of compound (III), e.g. at least 0.1 mol %, at least 1, at least 2, at least 5, or at least 10 mol % based on the amount of compound (III).
  • the amount of copper employed may be in the range from 0.01 to 50 mol % based on the amount of compound (III), in the range from 0. 1 to 25 mol %, 1 to 20 mol %, or in the range from 5 to 15 mol % based on the amount of compound (III).
  • the amount of copper is about 1 mol % based on the amount of compound (III), but may be up to 10 mol %.
  • the amount of ligand employed may be less than 100 mol %, based on the amount of compound (II), e.g. less than 50 mol %, less than 25 mol %, less than 20 mol %, less than 10 mol %, less than 5 mol %, less than 2 mol %, less than 1 mol %, less than 0.5 mol %, or even less than 0.1 mol % based on the amount of compound (II).
  • the amount of ligand employed may be at least 0.01 mol % based on the amount of compound (II), e.g.
  • the amount of ligand employed may be in the range from 0.01 to 100 mol % based on the amount of compound (II), in the range from 1 to 50 mol %, 5 to 40 mol %, 10 to 30 mol %, or in the range from 15 to 25 mol % based on the amount of compound (II).
  • the amount of ligand employed may be less than 100 mol %, based on the amount of compound (III), e.g. less than 50 mol %, less than 25 mol %, less than 20 mol %, less than 10 mol %, less than 5 mol %, less than 2 mol %, less than 1 mol %, less than 0.5 mol %, or even less than 0.1 mol % based on the amount of compound (III).
  • the amount of ligand employed may be at least 0.01 mol % based on the amount of compound (III), e.g.
  • the amount of copper employed may be in the range from 0.01 to 100 mol % based on the amount of compound (III), in the range from 1 to 50 mol %, 5 to 40 mol %, 10 to 30 mol %, or in the range from 15 to 25 mol % based on the amount of compound (III).
  • the molar ratio of compound (II) to (III) may be in the range of from 10:1 to 1:10, 5:1 to 1:5, 2:1 to 1:2 or 1.2:1 to 1:1.2.
  • the molar ratio of compound (II) to compound (III) may be in the range of from 1.1:1 to 1:1.1, e.g. about 1:1.
  • the reactant ratio will be about 1:1.
  • a slight excess of the amide may be desired to ensure the entire norbornene compound has reacted as it is harder to separate from the product in subsequent work up.
  • the reactants may be fed one to the other over the course of the reaction in which case the ratio of reactants may vary considerably during the course of the reaction.
  • an aqueous workup may be achieved by the addition of water (or other aqueous solution), and filtering the product as a precipitate or extraction of the desired product with a suitable organic solvent.
  • the product may be isolated by removing any solvent present by distillation, e.g. under reduced pressure.
  • Purification of the product may be achieved by any one of a number of methods, e.g. distillation, recrystallization and chromatography.
  • X is F, Cl, Br, I, or a sulphonate, preferably Cl; in the presence of a catalyst, which catalyst comprises a copper and a ligand.
  • X is F, Cl, Br, I, or a sulphonate, preferably Cl; in the presence of a catalyst, which catalyst comprises a copper and a ligand.
  • X is F, Cl, Br, I, or a sulphonate, preferably Cl; in the presence of a catalyst, which catalyst comprises a copper and a ligand.
  • X is F, Cl, Br, I or a sulphonate, preferably Cl; in the presence of a catalyst, which catalyst comprises a copper and a ligand.
  • a compound of formula (II) may be a compound of formula (XXII), (XXIII) or (XXIV):
  • X is F, Cl, Br, I, or a sulphonate, preferably Cl;
  • a and Z are independently, hydrogen or C 1-6 alkyl.
  • Examples of the compounds of formula (XXII), (XXIII) and (XXIV) are the compounds of formula (XII) and (XV) and (XVIII) respectively:
  • X is F, Cl, Br, I, or a sulphonate, preferably Cl.
  • X is F, Cl, Br, I, or a sulphonate; using a suitable protecting reagent; (b) reacting the compound produced in step (a) with a compound of formula (XI):
  • Suitable protecting groups will be apparent to the skilled person and include, for example, alcohols, such as 1,2 alcohols, thiols, such as 1,2 thiols, amines, such as 1,2 amines and hydrazines.
  • step (a) may be a compound of formula (XXXII) or (XXXIII):
  • Y 2 and Y 3 are independently O, S, N; R 2 and R 3 are independently C 1-8 alkyl, wherein R 2 and R 3 are optionally joined to form a 5-8 membered ring; R 4 and R 5 are independently C 1-8 alkyl; X is F, Cl, Br, I, or a sulphonate.
  • step (b) may be a compound of formula (XXXV) or a compound of formula (XXXVI):
  • the method may comprise
  • the invention also provides a method of preparing a compound of formula (XXXV) or (XXXVI) as described in step (b).
  • the present invention also relates to compounds of the formula (XXXI), (XXXII), (XXXIII), (XXVII), (XVIII), (XXXV) or (XXXVI):
  • Y 2 and Y 3 are independently O, S, N; R 2 and R 3 are independently C 1-8 alkyl, wherein R 2 and R 3 are optionally joined to form a 5-8 membered ring; R 4 and R 5 are independently C 1-8 alkyl;
  • X is F, Cl, Br, I, or a sulphonate; excluding the following compounds of formula (XXXV): i. Y 2 is O, Y 3 is O, R 2 is C 3 H 7 -(n), R 3 is C 3 H 7 -(n); ii. Y 2 is O, Y 3 is O, R 2 is C 2 H 5 , R 3 is C 2 H 5 ; iii. Y 2 is O, Y 3 is O, R 2 and R 3 are together —CH 2 -CH 2 —.
  • X is Cl.
  • Aqueous or gaseous ammonia may be used, or an ammonium salt, such as ammonium acetate.
  • Suitable solvents e.g. THF, and reaction conditions may be selected by the person skilled in the art.
  • the acid chloride may be prepared as described, for example, in WO 04/035589.
  • the amide may be prepared by reacting ammonia with the ester of the corresponding heterocycle.
  • Compounds of formula (II) may be prepared using the methodology described in WO 04/035589, and WO 2007/068417, for example.
  • Compounds of formula (XII) may be prepared according to the following scheme:
  • the compounds of formula (XV), (XII) and (XVIII) may be prepared using methodology as described in WO 2007/068417.
  • Reactions a and c may be performed as described in WO 2007/068417, e.g. using a hydrogenation catalyst such as 5% Pd/C, 5% Raney Nickel, or 5% Rhodium on carbon, in a solvent such as methanol, ethanol, THF or ethyl acetate.
  • Reactions b may also be performed using the methodology described in WO 2007/068417 for the corresponding nitro/amine substituted norbornenes.
  • the extent of hydrogenation may also be controlled e.g. by using Wilkinson's catalyst (RhC1(PPh 3 ) 3 ).
  • Compound (XXVII) may be produced during the course of reaction a or b.
  • the compounds may be isolated according to known procedures, e.g. HPLC.
  • the invention provides the above methods in which the catalyst is replaced by a catalyst comprising iron and a ligand or palladium and a ligand.
  • the palladium may be a palladium atom or ion, and, for example, may be derived from any palladium salt, such as Pd(0) or Pd(II).
  • Suitable ligands include carbene and phosphene ligands.
  • the ligand or ligands maybe selected from the wide range of known phosphene or carbene ligands.
  • the ligand may be a xantphos ligand, a ferrocine biphosphine ligand, a JosiPhos ligand, a biaryl monophosphine ligand, and each may be optionally substituted.
  • the ligand may one described in Ikawa et al. J. Am. chem. Soc., 2007, 129, 13001-13007, e.g.
  • the ligand is A or D, more preferably D. It has been found herein that ligand D is an effective ligand when the catalyst comprises palladium and is relatively cheap.
  • Suitable ligands when the catalyst comprises palladium include those described in Singer et al. Tetrahedron Letters, 2006, 47, 3727-3731, e.g. one selected from ligands F, G, H, and I:
  • R z may be t-Bu or cyclohexyl; in compound G, R, may be t-Bu or i-Pr.
  • the ligand may be I when the catalyst comprises palladium.
  • the iron may be an iron atom or ion, and, for example, may be derived from any iron salt, e.g. Fe(II) or Fe(III), including iron oxides such as Fe 2 O 3 , FeO, iron halides such as FeCl 3 , iron oxohalides, e.g. Fe(ClO 4 ) 2 , salts such as Fe(acac) 3 .
  • iron salt e.g. Fe(II) or Fe(III
  • iron oxides such as Fe 2 O 3 , FeO
  • iron halides such as FeCl 3
  • iron oxohalides e.g. Fe(ClO 4 ) 2
  • salts such as Fe(acac) 3
  • iron catalysts to form aryl C—N has been reported in the literature, e.g. Correa and Bolm, Angew. Chem. Int. Ed., 2007, 46, 8862-8865; Taillefer et al., Angew.
  • Suitable ligands include diamines, amino acids, amino alcohols, and phosphines.
  • the ligand or ligands may be one described in any of Correa and Bolm, Angew. Chem. Int. Ed., 2007, 46, 8862-8865; Taillefer et al., Angew. Chem., 2007, 119, 952-954; Correa et al., Chem. Soc. Rev., 2008, 37, 1108-1117, e.g. an optionally substituted 1,2-dimaine, e.g. N,N′-dimethylethylenediamine(DMEDA), a dione, such as 2,2,6,6-tetramethyl-3,5-heptanedione, or acetylacetonate.
  • DMEDA N,N′-dimethylethylenediamine
  • the catalyst may comprise a mixture of different types of metals, such as a mixture of two or all of Fe, Pd and Cu.
  • the catalyst may comprise a mixture of Cu and Fe, Cu and Pd, Pd and Fe, or Pd, Fe and Cu, in particular a mixture of Cu and Fe.
  • reaction conditions described above for copper based catalysts are also appropriate for catalysts comprising palladium or ion.
  • the blue suspension was stirred at room temperature, whilst adding 3-Difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid amide (1.76 g, 10 mmol), potassium carbonate (2.9 g, 21 mmol) and 5-Chloro-9-isopropyl-1,2,3,4-tetrahydro-1,4-methano-naphthalene (2.20 g, 10 mmol).
  • the resulting blue suspension was stirred overnight at 150° C. After this time, the suspension was cooled and diluted with acetone (15 mL), and the reaction mass filtered through a pad of Celite, washing with acetone (25 mL). The resulting solution was concentrated in vacuo to give a pale brown-brown solid.
  • the product yield was 80%; the solid strength was 92%.
  • the in situ product yield was 88% when 5-Chloro-9-isopropyl-1,2,3,4-tetrahydro-1,4-methano-naphthalene added last and 26% when 3-Difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid amide added last, the remainder being starting materials.
  • Example 3 The method described in Example 3 was repeated in a range of solvents at different temperatures, see Table 1.
  • the suspension was heated with stirring to 150° C., and allowed to stir at this temperature for 2 hours prior to adding ligand N1-methyl-propane-1,3-diamine (0.31 mL, 44 mol %) and stirring at 150° C. overnight. After this time, a sample was removed for analysis by HPLC. Conversion was 64% as measured by HPLC.
  • Residual starting material can be recovered via extraction of the filtrate into diethyl ether followed by concentration in vacuo (150 mg, 4%).
  • n is for example 1 to 4.
  • Examples 10a, 10b and 10c can readily be telescoped into a single stage with protection/deprotection done in situ.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
US13/142,084 2008-12-24 2009-12-16 Methods for the preparation of fungicides Abandoned US20110257410A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/142,084 US20110257410A1 (en) 2008-12-24 2009-12-16 Methods for the preparation of fungicides

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14065008P 2008-12-24 2008-12-24
EP09163256.2 2009-06-19
EP09163256 2009-06-19
PCT/EP2009/067283 WO2010072631A1 (fr) 2008-12-24 2009-12-16 Procedes de preparation de fongicides
US13/142,084 US20110257410A1 (en) 2008-12-24 2009-12-16 Methods for the preparation of fungicides

Publications (1)

Publication Number Publication Date
US20110257410A1 true US20110257410A1 (en) 2011-10-20

Family

ID=42286925

Family Applications (3)

Application Number Title Priority Date Filing Date
US13/142,084 Abandoned US20110257410A1 (en) 2008-12-24 2009-12-16 Methods for the preparation of fungicides
US13/142,110 Active US8637678B2 (en) 2008-12-24 2009-12-16 Methods for the preparation of aryl amides
US14/108,885 Active US9169233B2 (en) 2008-12-24 2013-12-17 Methods for the preparation of aryl amides

Family Applications After (2)

Application Number Title Priority Date Filing Date
US13/142,110 Active US8637678B2 (en) 2008-12-24 2009-12-16 Methods for the preparation of aryl amides
US14/108,885 Active US9169233B2 (en) 2008-12-24 2013-12-17 Methods for the preparation of aryl amides

Country Status (10)

Country Link
US (3) US20110257410A1 (fr)
EP (2) EP2373625B1 (fr)
JP (2) JP2012513961A (fr)
CN (2) CN102300850A (fr)
AR (2) AR074982A1 (fr)
BR (2) BRPI0923401B1 (fr)
IL (2) IL213351A0 (fr)
MX (2) MX2011006426A (fr)
TW (2) TW201026647A (fr)
WO (2) WO2010072631A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010072631A1 (fr) * 2008-12-24 2010-07-01 Syngenta Limited Procedes de preparation de fongicides
CN102906072B (zh) * 2010-04-20 2014-07-02 先正达参股股份有限公司 吡唑羧酸酰胺的制备方法
MX2012012004A (es) * 2010-04-20 2012-12-17 Syngenta Participations Ag Proceso para preparar amidas de acidos carboxilicos pirazolicos.
US8524915B2 (en) 2010-04-20 2013-09-03 Syngenta Crop Protection Llc Process for the preparation of pyrazole carboxylic acid amides
WO2011131543A1 (fr) * 2010-04-20 2011-10-27 Syngenta Participations Ag Procédé de synthèse d'amides d'acide pyrazolecarboxylique
WO2012055864A1 (fr) * 2010-10-27 2012-05-03 Solvay Sa Procédé de préparation de pyrazole-4-carboxamides
TWI534126B (zh) * 2011-01-25 2016-05-21 先正達合夥公司 用於製備吡唑羧酸醯胺之方法
GB201104203D0 (en) 2011-03-11 2011-04-27 Syngenta Ltd Chemical process
CN105047164B (zh) * 2015-08-27 2017-09-29 深圳市华星光电技术有限公司 一种灰阶调整方法及装置
CN107935930A (zh) * 2017-12-01 2018-04-20 浙江工业大学 一种1‑甲基‑3‑二氟甲基‑1h‑吡唑‑4‑酰胺衍生物及其制备方法与应用
CN111138364A (zh) * 2018-11-01 2020-05-12 东莞市东阳光菌阳氢专利农药有限公司 一种氟苯醚酰胺的制备方法
CN110922285B (zh) * 2019-12-06 2022-08-23 上海合全药业股份有限公司 一种金属催化一锅法制备芳基伯酰胺的方法
WO2023044364A1 (fr) 2021-09-15 2023-03-23 Enko Chem, Inc. Inhibiteurs de protoporphyrinogène oxydase
WO2024077487A1 (fr) * 2022-10-11 2024-04-18 Syngenta Crop Protection Ag Procédé pour la préparation d'amides d'acide pyrazolecarboxylique

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747518A (en) 1995-04-11 1998-05-05 Mitsui Toatsu Chemicals, Inc. Substituted thiophene derivative and agricultural and horticultural fungicide containing the same as active ingredient
US20020173475A1 (en) 2001-04-16 2002-11-21 Asim Dasgupta Methods to inhibit viral replication
EP1390340B1 (fr) * 2001-04-24 2017-03-01 Massachusetts Institute Of Technology Formation par catalyse de cuivre de liaisons carbone-heteroatome et carbone-carbone
DE10215292A1 (de) 2002-02-19 2003-08-28 Bayer Cropscience Ag Disubstitutierte Pyrazolylcarbocanilide
ATE365719T1 (de) 2002-03-05 2007-07-15 Syngenta Participations Ag O-cyclopropyl-carboxanilide und ihre verwendung als fungizide
FR2840303B1 (fr) 2002-05-31 2005-07-15 Rhodia Chimie Sa Procede d'arylation ou de vinylation ou d'alcylynation d'un compose nucleophile
US20050234239A1 (en) * 2002-03-31 2005-10-20 Marc Taillefer Method of forming a carbon-carbon or carbon-heteroatom linkage
GB0224316D0 (en) 2002-10-18 2002-11-27 Syngenta Participations Ag Chemical compounds
GB0319949D0 (en) * 2003-08-26 2003-09-24 Univ Strathclyde Nucleic acid sequence identification
TW200526626A (en) * 2003-09-13 2005-08-16 Astrazeneca Ab Chemical compounds
KR101117412B1 (ko) * 2004-04-12 2012-02-29 에자이 알앤드디 매니지먼트 가부시키가이샤 피라졸 축합환 유도체의 제조 방법
MX2007014261A (es) 2005-05-18 2008-01-22 Wyeth Corp Inhibidores de 3-cianoquinolina de cinasa tpl2 y metodos de elaboracion y uso de los mismos.
CA2621228C (fr) * 2005-09-02 2014-05-27 Nissan Chemical Industries, Ltd. Compose de benzamide a substitution isoxazoline et agent de lutte contre les organismes nuisibles
CN101962363A (zh) * 2005-09-16 2011-02-02 先正达参股股份有限公司 酰胺的制备方法
PT1940813E (pt) * 2005-10-25 2011-01-20 Syngenta Participations Ag Derivados de amidas heterocíclicas úteis como microbicidas
BRPI0618545B1 (pt) 2005-11-15 2015-10-13 Syngenta Participations Ag processo para produção de carboxanilidas
PL1963251T3 (pl) 2005-12-12 2013-01-31 Syngenta Participations Ag Proces wytwarzania amin
FR2896503B1 (fr) * 2006-01-23 2012-07-13 Aventis Pharma Sa Nouveaux derives soufres d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
US8119643B2 (en) * 2006-03-20 2012-02-21 Synta Pharmaceuticals Corp. Benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
EP2060575A1 (fr) 2006-04-19 2009-05-20 Boehringer Ingelheim International GmbH Dihydrothienopyrimidines et leur utilisation pour traiter des maladies inflammatoires
BRPI0712680A2 (pt) * 2006-06-08 2012-11-20 Lilly Co Eli antagonistas de receptor de mch
EP2029530B1 (fr) * 2006-06-16 2012-09-19 Syngenta Participations AG Dérivés d'éthényle carboxamide utilisés comme microbicides
DE102006033090A1 (de) 2006-07-14 2008-01-24 Bayer Cropscience Ag Verfahren zum Herstellen von Alkylaniliden aus Halogenbenzolderivaten
MX2009001349A (es) 2006-08-04 2009-04-17 Takeda Pharmaceutical Derivado heterociclico fusionado y su uso.
EP2848610B1 (fr) * 2006-11-15 2017-10-11 YM BioSciences Australia Pty Ltd Inhibiteurs de l'activité de kinase
WO2010072631A1 (fr) * 2008-12-24 2010-07-01 Syngenta Limited Procedes de preparation de fongicides

Also Published As

Publication number Publication date
TW201026647A (en) 2010-07-16
US8637678B2 (en) 2014-01-28
US20110263869A1 (en) 2011-10-27
IL213344A0 (en) 2011-07-31
EP2373625B1 (fr) 2014-10-08
TW201023742A (en) 2010-07-01
JP2012513962A (ja) 2012-06-21
CN102264705A (zh) 2011-11-30
IL213344A (en) 2016-07-31
BRPI0923401B1 (pt) 2021-11-23
US20140107348A1 (en) 2014-04-17
MX2011006425A (es) 2011-07-20
MX2011006426A (es) 2011-07-20
JP2012513961A (ja) 2012-06-21
AR075498A1 (es) 2011-04-06
EP2373625A1 (fr) 2011-10-12
AR074982A1 (es) 2011-03-02
EP2370412A1 (fr) 2011-10-05
BRPI0923401A2 (pt) 2015-07-28
WO2010072631A1 (fr) 2010-07-01
CN102300850A (zh) 2011-12-28
IL213351A0 (en) 2011-07-31
BRPI0923527A2 (pt) 2016-08-09
US9169233B2 (en) 2015-10-27
WO2010072632A1 (fr) 2010-07-01
JP5727381B2 (ja) 2015-06-03

Similar Documents

Publication Publication Date Title
US20110257410A1 (en) Methods for the preparation of fungicides
US8030527B2 (en) Process for preparing substituted biphenyls
CN107074738B (zh) 用于制备2-取代的-1,4-苯二胺及其盐的方法
KR100880787B1 (ko) 3,3',5,5',6,6'-헥사알킬-2,2'-비페놀,3,3',4,4',5,5'-헥사알킬-2,2'-비페놀 및3,3',4,4',5,5',6,6'-옥타알킬-2,2'-비페놀의 제조 방법
US10239831B2 (en) Method for producing bis(3-aminophenyl)disulfides and 3-aminothiols
US7737301B2 (en) Process for the production of anilines
US7820830B2 (en) Process for the production of carboxanilides
CN107428648B (zh) 用于制备可用于合成美托咪定的诸如3-芳基丁醛的化合物的方法
US9376384B2 (en) Diaryliodonium salt
US9447017B2 (en) Process for the production of 4-alkanoyloxy-2-methylbutanoic acid
US7141693B2 (en) Process for producing β-oxonitrile compound or alkali metal salt thereof
EP0822188A1 (fr) Procédé pour la préparation de bis-(2-hydroxyphenyl-3-benzotriazole)-méthanes
US6750343B2 (en) Methods for preparing 5- and 6-benzyl-functionalized quinoxalines
US20190218181A1 (en) Process for the manufacture of hydroxy-substituted aromatic compounds
TWI796463B (zh) 製備2,6-二烷基苯基乙酸之方法
JPH05271135A (ja) ビスフェノールの製造方法並びにビスフェノール

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION